Pfizer-Allergan merger is latest sign of deal makers’ silly pills

Steven Davidoff Solomon writes for The New York Times, Nov. 14, 2015

Pfizer wants to acquire Allergan not to build a better business by bringing together the makers of Botox and Viagra, but because the move will lower its taxes.